How can real-world registry data be used to augment clinical trial data

In this 3rd webinar session “How can real-world registry data be used to augment clinical trial data to improve drug development and regulatory decision making” held on the 13th of February 2025, we discussed the following topics:
 

• How registry data can be used for early development decision making
• How real-world evidence has contributed to regulatory decision making in marketing authorisation applications at the EMA
• Patients’ perspectives on real-world data

The information slides (.pdf) that were presented during the webinar can now be viewed.

You can also watch the webinar online (YouTube video):